Month: March 2014

By Lavinia Mo, Sui-Lee Wee and Li Hui GANZHOU, China (Reuters) – Lu Libing knew he had only one choice as the birth of his third child approached. On the Internet he found "A Home Where Dreams Come True", a website touted as China's biggest online adoption forum, part of an industry that has been largely unregulated for years. Expectant couples, unwilling or unable to keep their children, go to the website looking for adoptive parents rather than abort their babies or abandon them. There are no clear statistics on how many people use these websites but "A Home Where Dreams Come True" said 37,841 babies had been adopted through its website from 2007 to August 2012.

By David Stanway BEIJING (Reuters) – China’s war on pollution is only a few weeks old, but the battle lines are already being drawn between Beijing and Hebei, the province most synonymous with dirty air. A succession of Hebei officials used the annual session of parliament in Beijing this month to urge the central government to boost subsidies to help with job losses and other costs from mandated cuts in industrial production across the country. One local official said Hebei was taking on too much of the burden. The pleas came after Premier Li Keqiang, in his opening address to parliament on March 5, declared war on pollution in an attempt to head off growing anger over the quality of China’s air, water and soil.

A drug that was used in the time of the pharaohs for rheumatism has proven highly effective in treating recurrent bouts of pericarditis, an inflammation of the sac surrounding the heart, according to findings of a new clinical trial. The ancient medicine, colchicine, which has also been used for centuries as an anti-inflammatory agent for acute gout, was tested against placebo in a 240-patient pericarditis trial. The rate of recurring pericarditis was nearly halved for those taking colchicine compared with placebo, according to data presented on Sunday at the annual scientific sessions of the American College of Cardiology in Washington. The condition, which causes sharp chest pain, recurred in 42.5 percent of those taking dummy pills, compared with 21.6 percent of those who got colchicine.